Artificial Disc Market Report, By Type (Cervical Artificial Disc, Lumbar Artificial Disc), By Material (Metal on Metal, Metal on Biopolymer), By Indication (Spinal Trauma, Degenerative Disc Disease [DDD]), By End-Use (Hospitals, Specialty Clinics, Ambulatory Surgical Centers, Others) and Regions 2024-2032

Market Overview:

"The global artificial disc market was valued at US$ 1.6 Billion in 2023 and is expected to register a CAGR of 11.1% over the forecast period and reach US$ 4.1 Bn in 2032."

Report Attributes	Details
Base Year	2023
Forecast Years	2024-2032
Historical Years	2021-2023
Artificial Disc Market Growth Rate (2024-2032)	11.1%

Artificial disc replacement is advised for patients when the discs or intervertebral discs, which are the spongy cushions that separates the bones of the spine or vertebrae, and provide shock absorption, maintain stability of the spine, and provide pivot points for the vertebrae to move, are significantly damaged or worn. The natural discs function normally, but can be affected by injury, damage to intervertebral disc, and Degenerative Disc Disease (DDD), which gradually worsens Range of Motion (ROM). Spinal disc replacement or implant of artificial discs is also suggested for individuals suffering from chronic back or neck pain due to damage or wear down of discs over time, leading to lower back and neck pain.

A majority of artificial discs are designed with plates that attach to the vertebrae and each have a rotational component that fits between the fixation plates. The components are designed to withstand stress and rotational forces over long periods of time, but can also be affected by wear. Most artificial disks are made of metal, while some are produced using a combination of metal and plastic. Widely used materials include medical grade plastic (polyethylene) and medical grade cobalt chromium or titanium alloy.

Degenerative disc disease or DDD is a primary cause or reason for artificial disc treatment or implant to be advised or prescribed, and this condition has been registering a significant incline in recent times. Artificial disc replacement is more likely an option for patients aged between 18 and 60 years, with DDD at one or two levels of the spine, and whose condition has not shown any response to at least six previous months of non-surgical therapy.

Artificial discs are designed and intended as an alternative for spinal fusion surgery, during which the damaged disc is replaced with bone from the hip of a patient or from a bone bank. Artificial disc replacement is also known as arthroplasty, and is the process of replacing a damaged spinal disc with an artificial or manufactured disc. These products are designed to support the vertebrae while still allowing the recipient to bend forward, backwards, or side-to-side, and also swivel or turn.

Artificial Disc Market Trends and Drivers:

Rising prevalence of degenerative disc disease, back pain and spinal conditions, particularly among the geriatric population, but also among younger individuals experiencing pain and mobility issues as a result of poor lifestyle and habits, birth disorders, sports injuries, and accidental spine injuries and related conditions, is a major factor supporting growth of the artificial disc market.

Also, increasing preference for artificial disc treatment and implant to preserve natural spine movement and reduce degeneration of adjacent discs or segments over spinal fusion and other temporary remedies is supporting market growth to a major extent. Technological advancements in artificial disc design and new materials are also playing a major role in the market.

Use of more improved biocompatible materials and development of minimally-invasive surgical techniques are serving to enhance safety and efficacy of products and adding acceptability and appeal to procedures. In addition, investments in Research & Development (R&D) by major companies in the market is leading to steady development and introduction of next-generation products that offer better outcomes and present fewer complications to patients and healthcare personnel.

Artificial Disc Market Restraining Factors:

A major factor restraining potential market growth is high cost of implants, which limits access and affordability for numerous patients, specifically in regions with limited healthcare resources and unfavorable reimbursement framework.

Also, securing regulatory approvals and meeting compliance requirements can be costly, and can entail repeated and time-intensive processes, which can lead to delays in introduction of new medical devices, products, and procedures in the market. This can also hamper potential innovation and new product development due to uncertainties and associated risks. Some potential risks and complications associated with treatments involving artificial disc implants and surgery include complications resulting from surgery, device failure, infection, and/or nerve damage. These risks can impact preference for such procedures and treatments to a major extent.

Availability of effective alternatives such as spinal fusion surgery and non-surgical treatments does have an impact on demand for procedures to implant artificial discs. Some of the alternatives are well-established and may be perceived as safer and more reliable, and hence offer better patient outcomes.

Lack of long-term clinical evidence and data regarding the efficacy and durability of artificial disc treatment is another factor that can have a moderate effect on preference and cause hesitation. These factors collectively have a sizable impact on market growth, and the trend is expected to remain over the forecast period.

Artificial Disc Market Opportunities:

The global artificial disc market presents companies with a number of lucrative opportunities for growth and expansion, driven by factors such as continuous innovation and rising demand for innovative spinal procedures. Continuous advancements in technology and materials are accelerating the development of next-generation artificial disc implants, providing enhanced durability, functionality, and patient outcomes. As healthcare systems across the globe prioritize minimally invasive treatments and patient-centric care, acceptance and incorporation of artificial disc technology as a preferred choice to conventional fusion surgeries is expected to incline steadily.

In addition, companies can leverage opportunities through development and introduction of new and innovative solutions to address unmet clinical needs. Securing approval for novel artificial disc designs and surgical techniques from regulatory authorities will serve to open up avenues for new market entry and expansion. This will also enable improvements in treatment alternatives and enhance patient care.

Artificial Disc Market Segmentation:

By Type

• Cervical Artificial Disc
• Lumbar Artificial Disc

The cervical artificial disc segment is expected to account for a significantly larger share than the other type segments in the global artificial disc market. Some key factors include rising incidence of cervical spine disorders, increasing adoption of cervical artificial disc replacements as an alternative to fusion surgeries, and advancements in surgical techniques specifically tailored for cervical disc pathology are currently driving revenue growth of this segment.

By Material

• Metal on Metal
• Metal on Biopolymer

The metal on biopolymer segment is expected to continue to accounts for largest revenue share among the material segments in the global artificial disc market. This can be attributed to superior biomechanical properties, such as flexibility and durability, which closely mimic natural spinal movement. In addition, metal on biopolymer implants provide reduced wear rates and enhanced compatibility with surrounding tissues, adding to wider adoption and preference among surgeons and patients alike compared to other materials.

By Indication

• Spinal Trauma
• Degenerative Disc Disease (DDD)

The Degenerative Disc Disease (DDD) segment is expected to account for largest revenue share among the indication segments in the global artificial disc market owing to high prevalence of DDD among the aging population. Also, conditions such as degenerative disc disease and herniated discs add significantly to spinal morbidity, and artificial disc replacements is a viable treatment alternative to alleviate pain, restore mobility, and preserve spinal function in affected patients. Increasing number of individuals seeking treatment for various conditions, including DDD, and requiring artificial disc replacement is expected to continue to support revenue growth of this segment over the forecast period.

By End Use

• Hospitals
• Specialty Clinics
• Ambulatory Surgical Centers
• Others

Ambulatory surgical centers segment is expected to account for a dominant revenue share among the other end-use segments in the global artificial disc market. This dominance can be attributed to increasing patient preference for minimally invasive treatments as outpatients and cost-effectiveness of surgical processes provided by ambulatory Centers compared to conventional hospital settings. In addition, ambulatory centers often offer specialized care customized to orthopaedic and spinal procedures, and such benefits are expected to add support to significance of artificial disc surgeries in ASCs.

By Region

North America

• United States
• Canada

Europe

• Germany
• United Kingdom
• France
• Italy
• Spain
• Russia
• Poland
• Benelux
• Nordic
• Rest of Europe

Asia Pacific

• China
• Japan
• India
• South Korea
• ASEAN
• Australia & New Zealand
• Rest of Asia Pacific

Latin America

• Brazil
• Mexico
• Argentina

Middle East & Africa

• Saudi Arabia
• South Africa
• United Arab Emirates
• Israel
• Rest of MEA

The global artificial disc market is divided into five key regions: North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. North America accounts for a significantly larger market share owing to robust research initiatives, favorable healthcare reimbursement framework, and a substantially large patient population. Among the countries, the United States has leading in terms of adoption of artificial disc technologies. Growth of this market is also supported by rising incidence of degenerative bone diseases, increasing number of cases of lower back pain and conditions, and rising awareness regarding effective spinal disc replacement procedures. Also, primary healthcare providers are actively enhancing accessibility to meet inclining demand for disc replacement procedures, and these factors collectively are expected to support revenue growth of the North America market.

Europe market share incline is supported substantially by revenue share contribution from Germany and the United Kingdom, which have presence of robust healthcare frameworks and patient awareness regarding these procedures is high.

The Asia Pacific market has been registering rapid revenue growth with China and India emerging as key markets due to rising healthcare investments, increasing prevalence of spinal disorders, and expanding medical tourism trend.

Leading Companies in Artificial Disc Market & Competitive Landscape:

The global artificial disc market features a competitive landscape marked by high-level of rivalry among the leading players seeking to maintain and improve their market positions. Key companies employ varied strategies such as collaborations, mergers and acquisitions, and product innovations to gain a competitive advantage. In addition, strategic partnerships with healthcare facilities and surgeons, along with comprehensive marketing efforts, are employed to diversify market reach and customer base. Continuous investment in research and development to introduce advanced technologies and enhance product efficacy further intensifies competition in this dynamic market segment.

These companies include:

• AxioMed LLC
• Simplify Medical, Inc.
• Stryker
• Orthofix
• Globus Medical
• Johnson & Johnson Services, Inc.
• B. Braun Melsungen AG
• Zimmer Biomet
• Medtronic
• LDR Holding Corporation
• NuVasive, Inc.
• joimax GmbH
• VTI - Vertebral Technologies, Inc.
• K2M, Inc.
• RTI Surgical
• SYNERGY SPINE SOLUTIONS INC.
• NGMedical GmbH
• ZimVie Inc.

Recent Key Developments:

• In February 2024, NGMedical GmbH, which is a medical device manufacturer specializing in innovative spinal technologies, announced successful completion and launch of the first surgery involving the MOVE-C Artificial Cervical Disc in the United Arab Emirates.
• In January 2023, the DISC Surgery Centre in California, United States, completed its 1000th artificial disc replacement treatment. The surgery set a high standard for the facility, with an impressive postoperative satisfaction rate of 98%.
• In August 2023, ZimVie secured approval for a modified version of its Mobi-C spinal implant. Mobi-C was the first cervical disc approved in the U.S. to treat more than one level of the cervical spine.

Artificial Disc Market Research Scope

Report Metric	Report Details
Artificial Disc Market Size available for the years	2021-2023
Base Year	2023
Forecast Period	2024-2032
Compound Annual Growth Rate (CAGR)	11.1%
Segment covered	Type, Material, Indication, End Use
Regions Covered	North America:  The U.S. & Canada Latin America: Brazil, Mexico, Argentina, & Rest of Latin America Asia Pacific: China, India, Japan, Australia & New Zealand, ASEAN, & Rest of Asia Pacific Europe: Germany, The U.K., France, Spain, Italy, Russia, Poland, BENELUX, NORDIC, & Rest of Europe The Middle East & Africa:  Saudi Arabia, United Arab Emirates, South Africa, Egypt, Israel, and Rest of MEA
Fastest Growing Country in Europe	UK
Largest Market	North America
Key Players	AxioMed LLC, Simplify Medical, Inc., Stryker, Orthofix, Globus Medical, Johnson Johnson Services, Inc., B. Braun Melsungen AG, Zimmer Biomet, Medtronic, LDR Holding Corporation, uVasive, Inc., joimax GmbH, VTI - Vertebral Technologies, Inc., K2M, Inc., RTI Surgical, SYNERGY SPINE SOLUTIONS INC., NGMedical GmbH, and ZimVie Inc.